By: Daniel Trecroci
Peripheral arterial disease (PAD) affects up to 12 million Americans, causing symptoms that range from leg pain to gangrene or ulcerations resulting from lack of blood flow. Untreated, PAD can lead to possible amputation.
A new laser technology may provide an alternative to amputation. Unlike bypass surgery or angioplasty and stenting techniques, the CLiRpath laser can vaporize blockages in the arteries in the leg and foot. According to a press release by CLiRpath maker Spectranetics Corp., in clinical trials, limb salvage was observed in 95 percent of patients surviving to six months in people doing CLiRpath therapy.
For more information, visit the Web site at www.clirpath.com.